| This article has been cited by |
| 1 | Neoteric advancement in TB drugs and an overview on the anti-tubercular role of peptides through computational approaches | |
| Ameer Khusro,Chirom Aarti,Alberto Barbabosa-Pliego,Abdelfattah Z.M. Salem |
| Microbial Pathogenesis.2018;114()80 |
| [DOI] |
|
| 2 | Homology modelling and virtual screening to explore potent inhibitors for MAP2K3 protein | |
| Manan Bhargavi,Nazmina Vhora,Goverdhan Lanka,Gururaj Somadi,Sivan Sree Kanth,Alok Jain,Sarita Rajender Potlapally |
| Structural Chemistry.2021;32(3)1039 |
| [DOI] |
|
| 3 | Homology modelling and virtual screening to explore potent inhibitors for MAP2K3 protein | |
| Laurent Maveyraud |
| Structural Chemistry.2017;32(3)89 |
| [DOI] |
|
| 4 | A review on anti-tuberculosis peptides: Impact of peptide structure on anti-tuberculosis activity | |
| Sutharsana Yathursan,Siouxsie Wiles,Hannah Read,Vijayalekshmi Sarojini |
| Journal of Peptide Science.2019;25(11)89 |
| [DOI] |
|
| 5 | Natural Compounds Activities against SARS-CoV-2 Mpro through Bioinformatics Approaches for Development of Antivirus Candidates | |
| Taufik Muhammad Fakih |
| Jurnal Kimia Sains dan Aplikasi.2021;24(5)170 |
| [DOI] |
|
| 6 | Screening approaches and therapeutic targets: The two driving wheels of tuberculosis drug discovery | |
| Summaya Perveen,Rashmi Sharma |
| Biochemical Pharmacology.2022;197(5)114906 |
| [DOI] |
|
| 7 | Host Antimicrobial Peptides: The Promise of New Treatment Strategies against Tuberculosis | |
| Javier Arranz-Trullén,Lu Lu,David Pulido,Sanjib Bhakta,Ester Boix |
| Frontiers in Immunology.2017;8(5)114906 |
| [DOI] |
|
| 8 | Host Antimicrobial Peptides: The Promise of New Treatment Strategies against Tuberculosis | |
| Ameer Khusro,Chirom Aarti,Mona M.M.Y. Elghandour,Abdelfattah Z.M. Salem |
| Frontiers in Immunology.2021;8(5)229 |
| [DOI] |
|
| 9 | Role of Antimicrobial Peptides in Treatment and Prevention of Mycobacterium Tuberculosis: A Review | |
| Kanchan Mehta,Prince Sharma,Shama Mujawar,Ashish Vyas |
| International Journal of Peptide Research and Therapeutics.2022;28(5)229 |
| [DOI] |
|
